/COMUNICAE/
The Allurion program is a non-invasive, fully effective, safe and with optimal results
La World Health Organization (WHO), has declared the obesity and overweight as a global epidemic. Obesity is a Chronic disease high prevalence characterized by excessive increase in body fat and may increase the risk of developing certain health problems such as Type 2 diabetes, High blood pressure, heart disease, sleep apnea, fatty liver diseaseamong many others, besides the emotional and social. Overweight refers to a greater body weight than considered normal or healthy for a certain stature; it is usually additional body fat.
Information produced by the Health Education Group for Citizenship of the Spanish Society of Internal Medicine (SEMI)obesity is an excessive accumulation of fatty tissue, in body fat, caused by an increase in calories consumption from food and beverages. To maintain a normal weight you should eat a proper amount of calories. A BMI (Corporal Mass Index) between 18.5 and 25. This data is calculated by dividing the weight between the stature to the square, i.e. BMI = Kg. /m2. There is overweight if this baremus is between 26 and 30 and obesity between 31 and 40, if it is greater than 40 is a morbid obesity.
According to the recent European Health Survey in Spain44% of men and 31% of women are overweight. Differences between men and women are greater than in the case of obesity, and the percentage of men who are overweight in all age groups is higher.
Data from the Spanish Society of Obesity (Seedo), shows that between 16 and 30 years, has overweight or obesity in Spain and eight out of ten acknowledges excess weight as a disease that conditiones many aspects of their life.
Most people with overweight and/or obesity have tried to lose kilos by following advice and using unsupported products scientifically and without the advice of a specialist. Significado de los nombres
The programme Allurion weight loss Institute of Obesity Madrid is a non-invasive procedure, totally effective, safe and with optimal results.
The doctor. Adelardo Caballero Díaz, Director of the Institute of Obesity, accredited specialist General surgery and Digestive device, stands out for its extensive activity in bariatric surgery, laparoscopic, endoscopic and unique port, recommends this effective and resolutive solution for overweight and moderate obesity. “The programme Allurion consists of the implantation of a intragastric balloon that swallows in the form of Ingerible capsule under x-rays with a catheter, which then detaches from the device, and once placed in the stomach an X-ray is performed to check that it is in the right position. Then the ball is filled with physiological serum to occupy a part of the stomach and thus achieve a sensation of premature satiety when eating”, describes the doctor.
The result is a reduction in food consumed throughout the day and therefore a considerable weight loss safely and quickly.
The doctor. Adelardo Caballero explains that a number of requirements must be met to be a candidate for this procedure. “May the BMI be over 27, be between 18 and 65 and not be pregnant.”
AllurionIt's him. unique gastric ball that does not require endoscopy, nor anesthesia for placement and withdrawal and the total procedure lasts less than 20 minutes.
“After 16 weeks of therapy, it is undone and eliminated naturally, without the need for any medical procedure and patients will have lost an average of 15 Kg. We offer control and follow-up of 12 months by a multidisciplinary team, with physical, psychological and nutritional therapy,” explains Dr. Knight.
At the Obesity Institute, the patient, throughout the program, will receive constant advice from his doctor and an expert nutritionist. “In addition, you will have wireless supervision with connected smart scale technology and a mobile app that will follow, day by day, its progress,” says Adelardo Caballero.
Ingesible capsule, a therapeutic option for overweight and moderate obesity
The Allurion program is a non-invasive, fully effective, safe and with optimal results /COMUNICAE/ /COMUNICAE/
nails
en
https://images.correotemporalgratis.es/doityour.health/1220/dbmicrodb2-nails-ingesible-capsule-951-0.jpg
2023-04-11
Acording with the Digital Millennium Copyright Act (“DMCA”), Pub. L. 105-304 If you believe that your copyrighted work is being infringed, notify our team at the email [email protected]